PROPANC BIOPHARMA, INC. Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt
PROPANC BIOPHARMA, INC. (PPCB) reported Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt of $979.31 thousand for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-19.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt · last filed 2014-11-19
- PROPANC BIOPHARMA, INC. adjustments to additional paid in capital, equity component of convertible debt for the quarter ending 2014-09-30 was $979.31K.
| Period end | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt 3 month |
|---|---|
| 2014-09-30 | $979.31K 10-Q · filed 2014-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |